With the exception of historical information contained in this press release, the matters described herein are forward-looking statements that involve risks and uncertainties. MacroChem's actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed or referred to in the section entitled "Risk Factors" in MacroChem's Annual Report on Form 10-K, as well as those discussed elsewhere therein, and include, without limitation, risks regarding product development, the timing and results of clinical trials, the regulatory approval process, capital requirements, financial condition, patent protection and dependence on third parties for development and licensing arrangements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. MacroChem undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. For more information visit our website, http://www.macrochem.com.
MacroChem: Bernard Patriacca -- VP/CFO
email@example.com, (781) 489-7310
Investor Relations: The Investor Relations Group, Inc.
Christine Berni / Joseph Triunfo, (212) 825-3210
Bill Douglass / Michaela Heller, (212) 825-3210
|SOURCE MacroChem Corporation|
Copyright©2007 PR Newswire.
All rights reserved